Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020895

Expand all

VIAGRA (SILDENAFIL CITRATE)
EQ 25MG BASE
Marketing Status: Prescription

Active Ingredient: SILDENAFIL CITRATE
Proprietary Name: VIAGRA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 25MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020895
Product Number: 001
Approval Date: Mar 27, 1998
Applicant Holder Full Name: VIATRIS SPECIALTY LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIAGRA (SILDENAFIL CITRATE)
EQ 50MG BASE
Marketing Status: Prescription

Active Ingredient: SILDENAFIL CITRATE
Proprietary Name: VIAGRA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020895
Product Number: 002
Approval Date: Mar 27, 1998
Applicant Holder Full Name: VIATRIS SPECIALTY LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

VIAGRA (SILDENAFIL CITRATE)
EQ 100MG BASE
Marketing Status: Prescription

Active Ingredient: SILDENAFIL CITRATE
Proprietary Name: VIAGRA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020895
Product Number: 003
Approval Date: Mar 27, 1998
Applicant Holder Full Name: VIATRIS SPECIALTY LLC
Marketing Status:  Prescription
Patent and Exclusivity Information